PURPOSE: Our previously published data showed rapidly increasing rates of prostate cancer screening in men aged 50-74, which rose from 36 % in 2005 to 48 % in 2008.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Based on men's reported intentions at that time, this was expected to rise to 70 % in 2011. Here we report the actual rate of prostate cancer screening.
METHOD: Three nationwide observational telephone surveys (EDIFICE opinion polls) were conducted in 2005, 2008, and 2011. The overall target was a representative sample of >1,500 individuals living in France and aged 40-75 years, including 481 men aged 50-74 years.
RESULTS: Within this male population, the rate of screening reported remained stable between 2008 and 2011 (48 and 49 %, respectively). However, comparison of privileged versus disadvantaged populations showed significant differences, with a relative decrease in screening among those of higher socioprofessional status (p = 0.03) and from higher-income groups (p = 0.02). For households with a monthly income above 2,500< euro >, the screening rate decreased from 61 % in 2008 to 51 % in 2011 (p = 0.05), while for those with an income below 2,500< euro >, it increased from 36 % in 2008 to 44 % in 2011 (p = 0.18).
CONCLUSION: A plateau or even a reduction in prostate cancer screening is currently being observed; this is possibly due to progressive recognition among the population at large of the controversy surrounding prostate cancer screening, whereas this speculation was formerly limited to health-care professionals. After previously being more likely to undergo prostate cancer screening, it is the younger, wealthier populations that are currently showing the most noteworthy step backwards.
Eisinger F, Morère JF, Touboul C, Pivot X, Coscas Y, Blay JY, Lhomel C, Viguier J. Are you the author?
Paoli-Calmettes Institute, UMR_S912, Marseille, France.
Reference: Cancer Causes Control. 2015 Mar 31. Epub ahead of print.